UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000015795
Receipt No. R000017845
Official scientific title of the study Safety and efficacy of introduction ofgastric endoscopic submucosal dissection(ESD) by the gastric ESD beginners introduction after trining colorectal ESD
Date of disclosure of the study information 2014/12/01
Last modified on 2016/05/30 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Safety and efficacy of introduction ofgastric endoscopic submucosal dissection(ESD) by the gastric ESD beginners introduction after trining colorectal ESD
Title of the study (Brief title) Safety and efficacy of introduction ofgastric endoscopic submucosal dissection(ESD) by the gastric ESD beginners introduction after trining colorectal ESD
Region
Japan

Condition
Condition early gastric cancer/gastric adenoma
Classification by specialty
Gastroenterology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 The aim of this study is to assess the safety and efficacy of endoscopic submucosal dissection for gastric neoplasm by the gastric ESD beginners after training colorectal ESD
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes Completion rate
Key secondary outcomes operation time,complication rate,number of mucosal injection,volume of mucosal injection,en bloc resection rate

In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field.

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Maneuver
Interventions/Control_1 treatment
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required.

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients with early gastric cancer or gastric adenoma scheduled for endoscopic submucosal dissection from whom informed consent was obtained
Key exclusion criteria 1.Patients by whom infromed consent was not obtained
2.Pateints who have reccurent lesions
Target sample size 80

Research contact person
Name of lead principal investigator Yohei Minato/Kouichi Nonaka
Organization NTT Medical Centor Tokyo
Division name Department of Gastoroenterology
Address 5-9-22,Higashi-Gotanda,Shinagawa-Ku,Tokyo
TEL 03-3448-6111
Email yoheiminato55925@gmail.com

Public contact
Name of contact person Yohei Minato
Organization NTT Medical Centor Tokyo
Division name Department of Gastoroenterology
Address 5-9-22,Higashi-Gotanda,Shinagawa-Ku,Tokyo
TEL 03-3448-6111
Homepage URL
Email yoheiminato55925@gmail.com

Sponsor
Institute NTT Medical Centor Tokyo
Institute
Department

Sponsor means an organization that is responsible for plan, deployment and
report of the research including funding management. It doesn't mean
funding agency". Therefore, all clinical trial should have the one.

Funding Source
Organization NTT Medical Centor Tokyo
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2014 Year 12 Month 01 Day

Progress
Recruitment status Completed
Date of protocol fixation
2014 Year 10 Month 31 Day
Anticipated trial start date
2014 Year 12 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2014 Year 11 Month 30 Day
Last modified on
2016 Year 05 Month 30 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000017845